Shanghai Yingli Pharmaceutical Co., Ltd.
PrivateLast Round
Series A++
Mar 21, 2024
Total Funding Raised
$50M
Company Overview
Shanghai Yingli Pharmaceutical Co., Ltd. is a clinical-stage biotechnology company that researches and develops innovative oral small-molecule drugs for the treatment of oncology and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Yingli Pharmaceutical Co., Ltd. Comparables
Compare Shanghai Yingli Pharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sino Biopharmaceutical | 81% | |
| Innovent Biologics | 81% | |
| Secura Bio | 79% | |
Shanghai Yingli Pharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A++ | Mar 21, 2024 | ||||
| Series A Extension | Nov 8, 2023 | ||||
| Strategic | Feb 8, 2021 | ||||
| Series A | Feb 2, 2021 |
Shanghai Yingli Pharmaceutical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DYEE Capital | Series A Extension |
| 中南创投基金 | Series A |
| CICC Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2023
Raised Series A Extension round with CICC Capital and DYEE Capital.
- Feb 8, 2021
Raised $20M with Jiangsu Hengrui Pharmaceuticals Co., Ltd. as an investor.
Shanghai Yingli Pharmaceutical Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shanghai Yingli Pharmaceutical Co., Ltd.'s valuation, stock price, and market status.